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Identity 
Alias: Poikiloderma atrophicans and cataract 
Note 
Is a chromosomal instability syndrome with an 
increased risk of cancers.  
Inheritance 
Autosomal recessive; rare geno-dermatosis with 
increased frequency in females; 260 cases reported in 
the English medical literature. 
Clinics 
Note 
Clinical expression highly variable. 
Phenotype and clinics 
Main features include: 
-Growth retardation. 
-Skin defects appearing within the first year of life 
(90%) and persisting throuhout life: atrophic 
dermatosis, poikiloderma, hyperpigmentation, 
teleangiectasia. 
-Sparse hair which may progress to partial or total 
alopecia; dystrophic nails. 
-Photosensitivity. 
-Congenital skeletal defects - hypoplasia or absence of 
the radii and thumbs, osteopenia, cystic or sclerotic 
changes of the long bones - (>50%); bone age lower 
than chronological age. 
-Juvenile cataract, corneal dystrophy (50%). 
-Hypodontia. 
-Hypogonadism (25%). 
-Proportionate short stature. 
-Premature aging. 
Detailed definition of the clinical profile in a 
contemporary cohort of 41 RTS patients evidences 
some differences in the distribution of the clinical 
findings (figure 1), which should be kept into account 
to optimize diagnostic criteria. 
Diagnosis: the diagnosis is difficult before the 
development of the erythema; differential diagnosis 
with: 
-Werner syndrome,  
-Dyskeratosis congenita,  
-Cockayne syndrome,  
-Bloom syndrome,  
-Fanconi anaemia,  
-Anhidrotic ectodermal dysplasia. 
Neoplastic risk 
Patients have an enhanced risk of bone cancer, 
specifically osteosarcoma (30 out of 300 - 10%- in the 
literature) and nonmelanoma skin cancers (squamous 
cell carcinoma, basal cell carcinoma) with an estimated 
prevalence around 5%. 
Etiology: deficiency of RECQL4 helicase (see below), 
a protein involved in some aspect of replication and 
transcription, repair and recombination may suggest a 
mutational mechanism for cancer development, but the 
specificity for mesenchymal tumors is currently 
unknown. 
Treatment 
Only protection against sunlight is possible by means 
of sunscreens with both UVA and UVB protection; 
dermatologic therapies; surgical correction of skeletal 
malformations and cataracts;  
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regular and careful work-up of signs and symptoms of 
both cutaneous and internal malignancy; caution is 
warranted in administering chemotherapy to affected 
individuals due to their sensitivity to chemotherapeutic 
agents. 
Evolution 
The disease tends to progress during the first years of 
life, but becomes static so that patients may have a 
normal lifespan; the mortality from neoplastic disease 
during the second or third decade is very significantly 
increased. 
Cytogenetics 
Inborn conditions 
Spontaneous/induced chromatid breaks were found 
increased in only a very few studies; In contrast with 
(mainly negative) chromatid results, consistent 
clonal/non clonal structural chromosomal abnormalities 
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were evidenced in most studies, often involving 
chromosome 8, in cultured lymphocytes and in 
fibroblasts; low frequency trisomy 8 mosaicism has 
been reported in both lymphocyte and primary 
fibroblast cultures as well as in uncultured blood and 
buccal smears, indicating this characteristic 
chromosomal abnormality is present in vivo; a 
propensity to centromere misdivision with development 
of clones carrying isochromosomes, such as i(8q), 
i(8p), i(12p), i(12q) is peculiar of RTS. 
Cytogenetics of cancer 
Marked chromosomal instability has been detected in 
mesenchymal tumours developed by RTS sibs. 
Other findings 
Note 
Reduced unscheduled DNA synthesis, 37% of normal 
after exposure to ultraviolet C or gamma irradiation. 
Genes involved and proteins 
Note 
Mutations of RECQL4 gene, a member of the RECQ 
helicase genefamily, have been identified in a limited 
number of RTS patients. Molecular testing is available 
on a research basis and useful in confirming the 
diagnosis in suspected RTS patients carrying RECQL4 
mutations. 
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